Holen Sie sich die Stockscreener-App
8.53
1.31%
0.11
Handel nachbörslich:
8.34
-0.19
-2.23%
Schlusskurs vom Vortag:
$8.42
Offen:
$8.42
24-Stunden-Volumen:
5.41M
Relative Volume:
1.63
Marktkapitalisierung:
$608.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.96M
KGV:
-2.5848
EPS:
-3.3
Netto-Cashflow:
$-167.04M
1W Leistung:
+46.82%
1M Leistung:
+174.28%
6M Leistung:
+541.35%
1J Leistung:
+294.91%
1-Tages-Spanne:
$8.10
$9.50
1-Wochen-Bereich:
$5.78
$9.50
52-Wochen-Spanne:
$0.783
$9.50
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Firmenname
Ventyx Biosciences Inc
Sektor
Branche
Telefon
(858) 945-2393
Adresse
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Vergleichen Sie VTYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
8.53 | 600.42M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-11-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-03-21 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Buy |
| 2022-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-07 | Eingeleitet | Stifel | Buy |
| 2022-09-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-09 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-15 | Eingeleitet | Jefferies | Buy |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten
Why Ventyx Biosciences Inc. is moving todayAnalyst Downgrade & Safe Swing Trade Setup Alerts - newser.com
Is Ventyx Biosciences Inc. still worth holding after the dipPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Market reaction to Ventyx Biosciences Inc.’s recent newsWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Ashton Thomas Private Wealth LLC Takes Position in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Has Ventyx Biosciences Inc. formed a bullish divergenceMarket Performance Recap & Capital Efficient Trade Techniques - newser.com
Applying Elliott Wave Theory to Ventyx Biosciences Inc.2025 Macro Impact & Daily Stock Momentum Reports - newser.com
Will Ventyx Biosciences Inc. stock split again soonJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com
Ventyx Biosciences, Inc. (VTYX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Ventyx Biosciences Inc. stock supported by innovation pipeline2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Will Ventyx Biosciences Inc. see short term momentumWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Technical signs of recovery in Ventyx Biosciences Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Ventyx Biosciences Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Ventyx Biosciences (NASDAQ:VTYX) Hits New 1-Year HighHere's Why - MarketBeat
Is Ventyx Biosciences Inc. stock attractive for growth ETFsCPI Data & Accurate Entry and Exit Point Alerts - newser.com
How to recover losses in Ventyx Biosciences Inc. stock2025 Volatility Report & Verified Entry Point Detection - newser.com
Will Ventyx Biosciences Inc. stock benefit from infrastructure spendingJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Will Ventyx Biosciences Inc. stock see PE expansion2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Ventyx Biosciences (VTYX) Price Target Increased by 10.39% to 12.39 - MSN
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Sees Significant Decline in Short Interest - MarketBeat
Ventyx Biosciences (VTYX) to Release Earnings on Thursday - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Stock Price Up 9.2% Following Analyst Upgrade - MarketBeat
Can Ventyx Biosciences Inc. stock double in next 5 yearsQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
How Ventyx Biosciences Inc. stock reacts to global recession fears2025 Valuation Update & Safe Entry Zone Tips - fcp.pa.gov.br
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):